GGrantIndex
Sort

64,565 grants matching drug discovery

Broad spectrum antifungals targeting fatty acid biosynthesis

$483,500
Glen Palmer · University Of Tennessee Health Sci Ctr · R33 · FY2020 · AI

ADVANCING GENE-EDITING NUCLEASES FOR DIVERSE ZEBRAFISH APPLICATIONS

$483,476
Randall T Peterson · University Of Utah · R01 · FY2019 · GM

Automated Image-based Biomarker Computation Tools for Diabetic Retinopathy

$483,375
Kaushal Solanki · Eyenuk, Inc. · R42 · FY2016 · TR

Targeting Systems Vulnerabilities in the EGFR/HER3/HER2 Oncogenic Signaling Circuitry: New Precision Therapies for Oral Cancer

$483,360
J. Silvio Gutkind · University Of California, San Diego · R01 · FY2025 · DE

Targeting PPT1 in the Tumor Microenvironment

$483,340
Ravi K Amaravadi · Wistar Institute · P01 · FY2021 · CA

Drug Discovery for Fatty Acid Synthase in Oncology

$483,337
Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA

Biochemical Mechanisms of Long-Term Potentiation

$483,333
John David Sweatt · University Of Alabama At Birmingham · R01 · FY2010 · MH

Phosphodiesterase-2 and Mood Disorders: Target Validation and Drug Discovery

$483,316
James M O'Donnell · West Virginia University · RC1 · FY2009 · MH

Lipophilic antifolates and AIDS opportunistic infections

$483,292
Dana-Farber Cancer Institute · R01 · FY2002 · AI

The role of host glycans in Cryptosporidium development

$483,286
John M McEvoy · North Dakota State University · R15 · FY2016 · AI

Dissecting the mechanism of herpesvirus genome packaging

$483,285
Allison Louise Didychuk · Yale University · DP2 · FY2025 · AI

Role of chemokines in neuronal function and survival

$483,268
Olimpia Meucci · Drexel University · R37 · FY2025 · DA

Role of chemokines in neuronal function and survival

$483,268
Olimpia Meucci · Drexel University · R37 · FY2024 · DA

Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer

$483,257
Susan J Ramus · University Of New South Wales · R01 · FY2017 · CA

Computer Modeling of G Protein-Coupled Receptors

$483,256
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

Towards a generalizable drug discovery framework based on intrinsically disordered regions

$483,250
Gil Alterovitz · Brigham And Women'S Hospital · R01 · FY2020 · GM

TrmD-targeting actinobacterial natural products as next generation antibiotics

$483,241
Ya-Ming Hou · Thomas Jefferson University · R01 · FY2024 · AI

Electrical Stimulation of Human Myocytes in Microgravity: An In Vitro Model to Evaluate Therapeutics to Counteract Muscle Wasting

$483,238
Siobhan Malany · University Of Florida · UH3 · FY2021 · TR

CHEMICAL DIVERSITY LIBRARIES FROM MEDICINAL PLANTS (RMI)

$483,223
University Of North Carolina Chapel Hill · P41 · FY2005 · GM

Enzymes: Structure, Mechanism, Function and Inhibition

$483,214
Debra Dunaway-Mariano · University Of New Mexico · R01 · FY2009 · GM

Evidence-based Drug-Interaction Discovery: In-Vivo, In-Vitro and Clinical

$483,211
Lang Li · Indiana University Indianapolis · R01 · FY2014 · LM

Autoantigens for Diabetogenic CD4 T Cells

$483,129
Kathryn Haskins · University Of Colorado Denver · R01 · FY2011 · DK

The Discovery of Human Peptide Encoding Genes

$483,123
Alan Saghatelian · Salk Institute For Biological Studies · R01 · FY2024 · GM

The Discovery of Human Peptide Encoding Genes

$483,123
Alan Saghatelian · Salk Institute For Biological Studies · R01 · FY2023 · GM

The Discovery of Human Peptide Encoding Genes

$483,123
Alan Saghatelian · Salk Institute For Biological Studies · R01 · FY2022 · GM